These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 20125121
1. A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer. Crawford ED, Black L, Eaddy M, Kruep EJ. Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):162-7. PubMed ID: 20125121 [Abstract] [Full Text] [Related]
2. Cumulative cost pattern comparison of prostate cancer treatments. Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR. Cancer; 2007 Feb 01; 109(3):518-27. PubMed ID: 17186528 [Abstract] [Full Text] [Related]
3. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era. Carter CA, Donahue T, Sun L, Wu H, McLeod DG, Amling C, Lance R, Foley J, Sexton W, Kusuda L, Chung A, Soderdahl D, Jackmaan S, Moul JW. J Clin Oncol; 2003 Nov 01; 21(21):4001-8. PubMed ID: 14581423 [Abstract] [Full Text] [Related]
4. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000. McNaughton-Collins M, Walker-Corkery E, Barry MJ. J Natl Cancer Inst Monogr; 2004 Nov 01; (33):78-101. PubMed ID: 15504921 [Abstract] [Full Text] [Related]
5. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population. Sennfält K, Carlsson P, Thorfinn J, Frisk J, Henriksson M, Varenhorst E. Scand J Urol Nephrol; 2003 Nov 01; 37(3):226-31. PubMed ID: 12775282 [Abstract] [Full Text] [Related]
6. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH. Lung Cancer; 2005 Nov 01; 50(2):143-54. PubMed ID: 16112249 [Abstract] [Full Text] [Related]
7. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK. Fourcade RO, Benedict A, Black LK, Stokes ME, Alcaraz A, Castro R. BJU Int; 2010 Jan 01; 105(1):49-56. PubMed ID: 20132102 [Abstract] [Full Text] [Related]
8. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Brandeis J, Pashos CL, Henning JM, Litwin MS. Cancer; 2000 Oct 15; 89(8):1792-9. PubMed ID: 11042575 [Abstract] [Full Text] [Related]
9. Adenocarcinoma of the prostate: an expensive way to die. Piper NY, Kusada L, Lance R, Foley J, Moul J, Seay T. Prostate Cancer Prostatic Dis; 2002 Oct 15; 5(2):164-6. PubMed ID: 12497008 [Abstract] [Full Text] [Related]
10. Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer. Jayadevappa R, Bloom BS, Chhatre S, Fomberstein KM, Wein AJ, Malkowicz SB. J Urol; 2005 Sep 15; 174(3):1059-64; discussion 1064. PubMed ID: 16094058 [Abstract] [Full Text] [Related]
11. Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4). Andersson SO, Andrén O, Lyth J, Stark JR, Henriksson M, Adami HO, Carlsson P, Johansson JE. Scand J Urol Nephrol; 2011 Apr 15; 45(3):177-83. PubMed ID: 21265595 [Abstract] [Full Text] [Related]
13. The economic burden of prostate cancer, California, 1998. Max W, Rice DP, Sung HY, Michel M, Breuer W, Zhang X. Cancer; 2002 Jun 01; 94(11):2906-13. PubMed ID: 12115378 [Abstract] [Full Text] [Related]
14. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database. Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J. Clin Ther; 2009 Nov 01; 31(11):2653-64. PubMed ID: 20110008 [Abstract] [Full Text] [Related]
15. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines. Balu S. Clin Ther; 2009 Jul 01; 31(7):1581-94. PubMed ID: 19695408 [Abstract] [Full Text] [Related]
16. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA. Am J Geriatr Pharmacother; 2009 Oct 01; 7(5):262-70. PubMed ID: 19948302 [Abstract] [Full Text] [Related]
17. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database. Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators. Prostate Cancer Prostatic Dis; 2008 Oct 01; 11(3):280-7. PubMed ID: 17893700 [Abstract] [Full Text] [Related]
18. An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia. Black L, Naslund MJ, Gilbert TD, Davis EA, Ollendorf DA. Am J Manag Care; 2006 Mar 01; 12(4 Suppl):S99-S110. PubMed ID: 16551208 [Abstract] [Full Text] [Related]
19. Prostate cancer in Victoria in 1993: patterns of reported management. Frydenberg M, Giles GG, Mameghan H, Thursfield VJ, Millar J, Wheelahan JB, Bolton DM, Syme RR. Med J Aust; 2000 Mar 20; 172(6):270-4. PubMed ID: 10860092 [Abstract] [Full Text] [Related]
20. Prostate cancer. Penson DF, Chan JM, Urologic Diseases in America Project. J Urol; 2007 Jun 20; 177(6):2020-9. PubMed ID: 17509282 [Abstract] [Full Text] [Related] Page: [Next] [New Search]